30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
France Biotechnology & Medical Research

Nfl Biosciences SAS (ALNFL)

Track

The most recent insider trading activity occurred on September 2, 2025, with Bruno Lafont, the CEO, selling shares valued at approximately $41,470. Prior transactions by Lafont and Ignacio Faus in July and June 2023 also involved significant sell-offs. Overall, recent insider activity has been predominantly in the form of sales.
Stock chart
Ticker: ALNFL Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Bruno Lafont
Président Directeur Général
3 sales — total 41,401 EUR
Sale 2 Sep 2025
Value €3,134,438.51 | Price 361.47 | Shares 49,601
Sale 2 Sep 2025
Value €342,049.86 | Price 222.95 | Shares 39,198
Sale 2 Sep 2025
Value €27,405.00 | Price 1.52 | Shares 18,000
Sale 22 Jul 2025
Value €3,652,785.17 | Price 325.09 | Shares 65,048
Sale 22 Jul 2025
Value €4,490,935.38 | Price 136.88 | Shares 17,896
Sale 18 Jul 2023
Value €3,163.44 | Price 2.64 | Shares 1,200
Sale 18 Jul 2023
Value €3,240.00 | Price 2.70 | Shares 1,200
Sale 18 Jul 2023
Value €20,368.40 | Price 2.62 | Shares 7,765
Sale 18 Jul 2023
Value €16,954.64 | Price 2.58 | Shares 6,568
Sale 3 Jul 2023
Value €108,516.06 | Price 2.52 | Shares 43,000
Sale 30 Jun 2023
Value €151,272.30 | Price 2.65 | Shares 57,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-08 2025-09-02 S Sale
3.2
Bruno Lafont

Président Directeur Général

Executive Director
49,601
361.47
€3,134,439 		49,601 361.47 €3,134,439
2025-09-08 2025-09-02 S Sale
3.2
Bruno Lafont

Président Directeur Général

Executive Director
39,198
222.95
€342,050 		39,198 222.95 €342,050
2025-09-08 2025-09-02 S Sale
3.2
Bruno Lafont

Président Directeur Général

Executive Director
55,481
181.94
€3,430,095 		55,481 181.94 €3,430,095
2025-07-28 2025-07-22 S Sale
3.2
Bruno Lafont

Président Directeur Général

Executive Director
9,350
1.13
€10,550 		9,350 1.13 €10,550
2025-07-28 2025-07-22 S Sale
3.2
Bruno Lafont

Président Directeur Général

Executive Director
41,650
1.19
€49,490 		41,650 1.19 €49,490
2023-07-24 2023-07-18 S Sale
3.3
Ignacio Faus

Président Directeur Général

Executive Director
1,200
2.64
€3,163 		1,200 2.64 €3,163
2023-07-24 2023-07-18 S Sale
3.3
Ignacio Faus

Président Directeur Général

Executive Director
1,200
2.70
€3,240 		1,200 2.70 €3,240
2023-07-24 2023-07-18 S Sale
3.3
Ignacio Faus

Président Directeur Général

Executive Director
7,765
2.62
€20,368 		7,765 2.62 €20,368
2023-07-24 2023-07-18 S Sale
3.3
Ignacio Faus

Président Directeur Général

Executive Director
6,568
2.58
€16,955 		6,568 2.58 €16,955
2023-07-06 2023-07-03 S Sale
3.2
Bruno Lafont

Directeur Général Délégué

Officer
43,000
2.52
€108,516 		43,000 2.52 €108,516
2023-07-06 2023-06-30 S Sale
3.2
Bruno Lafont

Directeur Général Délégué

Officer
57,000
2.65
€151,272 		57,000 2.65 €151,272
Explore more

More insider trading research around Nfl Biosciences SAS

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe